PYR-41
SIGMA/N2915 - ≥98% (HPLC), powder
Synonym: 4[4-
CAS Number: 418805-02-4
Empirical Formula (Hill Notation): C17H13N3O7
Molecular Weight: 371.30
Linear Formula: C17H13N3O7
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | red to brown |
| form | powder |
| InChI | 1S/C17H13N3O7/c1-2-26-17( |
| InChI key | ARGIPZKQJGFSGQ-UKTHLTGXSA |
| Quality Level | 100 ![]() |
| SMILES string | CCOC(=O)c1ccc(cc1)N2NC(=O |
| solubility | DMSO: 5 mg/mL, clear (warmed) |
| storage temp. | −20°C |
| Application: | PYR-41 has been used as E1 inhibitor: • to determine the cellular degradation pathways on adeno-associated viruses (AAV) transduction • to assess its selectivity and potency by matrix assisted laser desorption/ionization-tim • to treat fully differentiated C2C12 myotubes in high glucose medium for determining its effect on protein ubiquitination and cell viability • in the pretreatment of human brain microvascular endothelial cells (hBMECs) for the inhibition studies before infection with bacteria |
| Biochem/physiol Actions: | PYR-41 inhibits E1 ubiquitin ligases like mouse double minute 2 homolog (MDM2), Itchy (ITCH) and HOIL-1L interacting protein (HOIP). It has anticancer potential. |
| Biochem/physiol Actions: | PYR-41 is a cell permeable inhibitor of Ubiquitin activating enzyme (E1) with little or no activity against E3, E2, or caspase enzymatic activity. |
| Biochem/physiol Actions: | PYR-41 is a cell permeable inhibitor of Ubiquitin activating enzyme (E1). |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H317 |
| Precautionary statements | P280 - P301 + P312 + P330 - P302 + P352 |
| Hazard Codes | Xn |
| Risk Statements | 22-43 |
| Safety Statements | 36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


